abstract |
The present invention relates to dopamine and serotonin receptor ligands having the general formula (I), wherein the meanings of R1-R9, W, n and X are as given in the claims and in the description. The compounds of the invention are useful in the treatment of certain psychiatric and neurological conditions, that is, schizophrenia, other psychoses, anxiety disorders, depression, migraine, cognitive diseases, ADHD and sleep improvement. |